A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Rezolute, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 180,421 shares of RZLT stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
180,421
Previous 330,081 45.34%
Holding current value
$1.07 Million
Previous $842,000 7.96%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$2.29 - $5.79 $342,721 - $866,531
-149,660 Reduced 45.34%
180,421 $775,000
Q1 2024

May 13, 2024

BUY
$0.95 - $2.55 $264,741 - $710,621
278,675 Added 542.11%
330,081 $842,000
Q4 2023

Feb 13, 2024

BUY
$0.74 - $1.24 $19,022 - $31,875
25,706 Added 100.02%
51,406 $51,000
Q3 2023

Nov 14, 2023

BUY
$1.32 - $2.1 $5,016 - $7,980
3,800 Added 17.35%
25,700 $34,000
Q2 2023

Aug 11, 2023

BUY
$1.75 - $2.33 $4,375 - $5,825
2,500 Added 12.89%
21,900 $43,000
Q1 2023

May 12, 2023

BUY
$1.79 - $2.87 $3,222 - $5,166
1,800 Added 10.23%
19,400 $37,000
Q4 2022

Feb 13, 2023

BUY
$1.38 - $2.84 $552 - $1,136
400 Added 2.33%
17,600 $36,000
Q3 2022

Nov 14, 2022

SELL
$2.19 - $3.49 $1,533 - $2,443
-700 Reduced 3.91%
17,200 $47,000
Q2 2022

Aug 12, 2022

BUY
$2.6 - $3.85 $46,540 - $68,915
17,900 New
17,900 $58,000

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $231M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.